Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C R Hay

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Lancet (London, England)|June 29, 1985
Progressive liver disease in haemophilia: an understated problem?C R Hay, F E Preston, D R Triger, et al.
Lancet (London, England)|November 23, 1985
Liver disease in haemophiliaC R Hay, F E Preston, D R Triger, et al.
Thrombosis and Haemostasis|June 1, 1997
Potential misdiagnosis of factor V Leiden: a comparison of two genotyping techniquesA M Cumming, S Keeney, A Salden, et al.
British Journal of Haematology|February 24, 2001
Aggressive multiple modality therapy for varicella-associated purpura fulminansD P Busuttil, C R Hay, M A Lewis, et al.
Blood|September 1, 1990
Induction of immune tolerance in patients with hemophilia A and inhibitors treated with porcine VIIIC by home therapyC R Hay, Y Laurian, F Verroust, et al.
Journal of Clinical Pathology|June 1, 1991
Anticardiolipin antibodies in leptospirosisF P Rugman, G Pinn, M F Palmer, et al.
Clinical Nephrology|January 7, 1999
Plasma thrombomodulin in renal disease: effects of renal function and proteinuriaR Rustom, H Leggat, H R Tomura, et al.
Lancet (London, England)|July 27, 1985
Non-A, non-B hepatitis and heat-treated factor VIII concentratesF E Preston, C R Hay, M S Dewar, et al.
Biochimica Et Biophysica Acta|August 18, 1994
Ineffectiveness of the inhibition of the main haemorrhagic metalloproteinase from Bothrops jararaca venom by its only plasma inhibitor, alpha 2-macroglobulinA S Kamiguti, H P Desmond, R D Theakston, et al.
Seminars in Hematology|April 1, 1993
Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitorsJ N Lozier, E Santagostino, C K Kasper, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Lancet (London, England)|June 29, 1985
Progressive liver disease in haemophilia: an understated problem?C R Hay, F E Preston, D R Triger, et al.
Lancet (London, England)|November 23, 1985
Liver disease in haemophiliaC R Hay, F E Preston, D R Triger, et al.
Thrombosis and Haemostasis|June 1, 1997
Potential misdiagnosis of factor V Leiden: a comparison of two genotyping techniquesA M Cumming, S Keeney, A Salden, et al.
British Journal of Haematology|February 24, 2001
Aggressive multiple modality therapy for varicella-associated purpura fulminansD P Busuttil, C R Hay, M A Lewis, et al.
Blood|September 1, 1990
Induction of immune tolerance in patients with hemophilia A and inhibitors treated with porcine VIIIC by home therapyC R Hay, Y Laurian, F Verroust, et al.
Journal of Clinical Pathology|June 1, 1991
Anticardiolipin antibodies in leptospirosisF P Rugman, G Pinn, M F Palmer, et al.
Clinical Nephrology|January 7, 1999
Plasma thrombomodulin in renal disease: effects of renal function and proteinuriaR Rustom, H Leggat, H R Tomura, et al.
Lancet (London, England)|July 27, 1985
Non-A, non-B hepatitis and heat-treated factor VIII concentratesF E Preston, C R Hay, M S Dewar, et al.
Biochimica Et Biophysica Acta|August 18, 1994
Ineffectiveness of the inhibition of the main haemorrhagic metalloproteinase from Bothrops jararaca venom by its only plasma inhibitor, alpha 2-macroglobulinA S Kamiguti, H P Desmond, R D Theakston, et al.
Seminars in Hematology|April 1, 1993
Use of porcine factor VIII for surgical procedures in hemophilia A patients with inhibitorsJ N Lozier, E Santagostino, C K Kasper, et al.
Pageof 7